Basic Information
ID: ALA5132826
Type: Binding
Description: Inhibition of ELOVL1 in human HEK2936E cells assessed as reduction of C26:0 LPC synthesis incubated for 48 hrs by cellular assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: HEK2936E
Target: Elongation of very long chain fatty acids protein 1(ALA6001)
Document: ALA5131397
Inhibition of ELOVL1 in human HEK2936E cells assessed as reduction of C26:0 LPC synthesis incubated for 48 hrs by cellular assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5132826
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 294.38 | 3.99 | 3.99 |
| 340.33 | 3.22 | 3.22 |
| 307.33 | 3.46 | 3.46 |
| 321.36 | 3.68 | 3.68 |
| 320.40 | 3.11 | 3.11 |
| 352.37 | 3.09 | 3.09 |
| 322.34 | 3.08 | 3.08 |
| 305.38 | 3.79 | 3.79 |
| 322.34 | 3.08 | 3.08 |
| 307.33 | 3.46 | 3.46 |
| 296.31 | 2.59 | 2.59 |
| 390.34 | 4.10 | 4.10 |
| 331.42 | 4.18 | 4.18 |
| 312.37 | 4.13 | 4.13 |
| 296.31 | 2.59 | 2.59 |
| 339.35 | 3.79 | 3.79 |
| 347.35 | 2.95 | 2.95 |
| 336.37 | 3.39 | 3.39 |
| 340.33 | 3.22 | 3.22 |
| 358.32 | 3.35 | 3.35 |
| 358.32 | 3.35 | 3.35 |
| 295.32 | 3.19 | 3.19 |
| 340.33 | 3.22 | 3.22 |
| 337.36 | 2.66 | 2.66 |
| 336.37 | 3.39 | 3.39 |
| 321.38 | 3.59 | 3.59 |
| 347.35 | 2.95 | 2.95 |
| 306.34 | 4.07 | 4.07 |
| 295.32 | 3.19 | 3.19 |
| 352.37 | 3.09 | 3.09 |
| 291.35 | 3.61 | 3.61 |
| 291.35 | 3.61 | 3.61 |
| 277.33 | 3.05 | 3.05 |
| 352.37 | 3.09 | 3.09 |
| 305.38 | 4.00 | 4.00 |
| 319.36 | 2.78 | 2.78 |
| 358.32 | 3.35 | 3.35 |
| 347.35 | 2.95 | 2.95 |
| 356.79 | 3.73 | 3.73 |
| 340.33 | 3.22 | 3.22 |
| 303.37 | 3.54 | 3.54 |
| 340.33 | 3.22 | 3.22 |
| 323.33 | 2.47 | 2.47 |
| 329.36 | 2.53 | 2.53 |
| 296.30 | 3.66 | 3.66 |
| 352.37 | 3.09 | 3.09 |
| 356.79 | 3.73 | 3.73 |